FDA 483 - Abaco Partners, LLC - November 10, 2021
Discuss this record with AI
Document or profile
One record shows the event. A profile shows the pattern.
Buy this document for the source file and details behind this single event.
Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.
Abaco Partners, LLC, a manufacturer in Grand Rapids, MI, was cited for multiple significant deficiencies across its quality system, production, and laboratory operations during an FDA inspection. Key issues include inadequate quality control procedures, insufficient employee GMP training, and poor record-keeping for annual drug reviews and batch production. The firm also failed in microbiological and stability testing programs, including using an unregistered lab and not adhering to stability protocols.
ID · f81206a2-1bde-49d3-ad1f-0c18189c3171